May 2014 newsletter illustrates production of mammalian metabolites by Hypha’s microbial biotransformation system

We are able to create mammalian metabolites as featured in our May 2014 newsletter, using Cyclosporin A as an example. In addition, we are also able to produce microbial derived metabolites which may have interesting, exploitable properties that have not previously been possible to explore.

Please click here for a PDF of Hypha’s May 2014 newsletter